Gonadal dysfunction in systemic diseases

European Journal of Endocrinology

Volumn 152, Issue 4, 2005, Pages 501-513

  Karagiannis, Asterios ^a,b   Harsoulis, Faidon ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIRHEUMATIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CALCITRIOL; CENTRAL NERVOUS SYSTEM AGENTS; CIMETIDINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; METHOTREXATE; METOCLOPRAMIDE; PAPAVERINE; PHENOTHIAZINE; PHENTOLAMINE; PROSTAGLANDIN E; PROSTAGLANDIN E1; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT SOMATOMEDIN C; SALAZOSULFAPYRIDINE; SILDENAFIL; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZINC;

ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; AMENORRHEA; ANEMIA; ANOREXIA NERVOSA; AZOOSPERMIA; CARDIOVASCULAR DISEASE; CELIAC DISEASE; CHROMOSOME DISORDER; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; ESTROGEN BLOOD LEVEL; FEMALE INFERTILITY; FEMINIZATION; GENOTOXICITY; GONAD DYSFUNCTION; GYNECOMASTIA; HEMOCHROMATOSIS; HORMONE RELEASE; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMPOTENCE; IN VITRO STUDY; IN VIVO STUDY; LIBIDO DISORDER; LIVER DISEASE; MALE INFERTILITY; MENORRHAGIA; METABOLIC SYNDROME X; NONHUMAN; OLIGOMENORRHEA; OLIGOSPERMIA; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RHEUMATIC DISEASE; SECONDARY HYPERPARATHYROIDISM; SPERMATOGENESIS; STARVATION; STEROID METABOLISM; SYSTEMIC DISEASE; TESTIS ATROPHY; TESTIS DISEASE; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL; ZINC DEFICIENCY;

CARDIOVASCULAR DISEASES; CELIAC DISEASE; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; MALE; METABOLIC SYNDROME X; OVARY; RHEUMATIC DISEASES; TESTIS; TESTOSTERONE;

EID: 17744391404     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01886     Document Type: Review

References (125)

1. Baker HWG. Testicular dysfunction in systemic disease. In Principles and Practice of Endocrinology and Metabolism, edn 3, ch. 116, pp 1150-1158. Ed. KL Becker. Philadelphia: Lippincott Williams & Wilkins, 2000.
2. Madersbacher S, Grunberger T & Maier U. Andrological status before and after liver transplantation. Journal of Urology 1994 151 1251-1254.
3. Samojlik E, Kirschner MA, Ribot S & Szmal E. Changes in the hypothalamic-pituitary-gonadal axis in men after cadaver kidney transplantation and cyclosporine therapy. Journal of Andrology 1992 13 332-336.
4. Baker HW, Burger HG, de Kretser DM, Dulmanis A, Hudson B, O'Connor S, Paulsen CA, Purcell N, Rennie GC, Seah CS, Taft HP & Wang C. A study of the endocrine manifestations of hepatic cirrhosis. Quarterly Journal of Medicine 1976 45 145-178.
5. Smith SR, Chhetri MK, Johanson J, Radfar N & Migeon CJ. The pituitary-gonadal axis in men with protein-calorie malnutrition. Journal of Clinical Endocrinology and Metabolism 1975 41 60-69.
6. Kyung NH, Barkan A, Klibanski A, Badger TM, McArthur JW, Axelrod L & Beitins IZ. Effect of carbohydrate supplementation on reproductive hormones during fasting in men. Journal of Clinical Endocrinology and Metabolism 1985 60 827-835.
7. Handelsman DJ & Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinology and Metabolism Clinics of North America 1993 22 145-161.
8. South SA, Yankow VI & Evans WS. Normal reproductive neuroendocrinology in the female. Endocrinology and Metabolism Clinics of North America 1993 22 1-28.
9. Leung PC & Steele GL. Intracellular signaling in the gonads. Endocrine Reviews 1992 13 476-498.
10. Burke CW & Anderson DC. Sex-hormone-binding globulin is an oestrogen amplifier. Nature 1972 240 38-40.
11. Loukovaara M, Carson M & Adlercrentz H. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. Journal of Clinical Endocrinology and Metabolism 1995 80 160-164.
12. Braunstein GD. Gynecomastia. New England Journal of Medicine 1993 328 490-495.
13. Patterson MN, McPhaul MJ & Hughes IA. Androgen insensitivity syndrome. Baillieres Clinical Endocrinology and Metabolism 1994 8 379-404.
14. Bannister P, Oakes J, Sheridan P & Losowsky MS. Sex hormone changes in chronic liver disease: a matched study of alcoholic versus non-alcoholic liver disease. Quarterly Journal of Medicine 1987 63 305-313.
15. van Thiel DH, Gavaler JS, Spero JA, Egler KM, Wright C, Sanghvi AT, Hasiba U & Lewis JH. Patterns of hypothalamic-pituitary-gonadal dysfunction in men with liver disease due to differing etiologies. Hepatology 1981 1 39-46.
16. Terasaki T, Nowlin DM & Pardridge WM. Differential binding of testosterone and estradiol to isoforms of sex-hormone-binding globulin: selective alteration of estradiol binding in cirrhosis. Journal of Clinical Endocrinology and Metabolism 1988 67 639-643.
17. Maria N, Colantoni A & van Thiel DH. The liver and endocrine function. In Principles and Practice of Endocrinology and Metabolism edn 3, ch. 205, pp 1870-1885. Ed. KL Becker. Philadelphia: Lippincott Williams & Wilkins, 2000.
18. Frias J, Torres JM, Miranda MT, Ruiz E & Ortega M. Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adults of both sexes. Alcohol and Alcoholism 2002 37 169-173.
19. Hasselblatt M, Krieg-Hartig C, Hufner M, Halaris A & Ehrenreich H. Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men. Alcohol and Alcoholism 2003 38 239-242.
20. Caufriez A, Reding P, Urbain D, Golstein J & Copinschi G. Insulin-like growth factor-I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. Journal of Endocrinological Investigation 1991 14 317-321.
21. Tajima Y, Watanabe D, Koshimizu U, Matsuzawa T & Nishimune Y. Insulin-like growth factor-I and transforming growth factor-alpha stimulate differentiation of type A spermatogonia in organ culture of adult mouse cryptorchid testes. International Journal of Andrology 1995 18 8-12.
22. Castilla-Cortazar I, Garcia M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, Diaz M & Prieto J. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology 2000 31 592-600.
23. Castilla-Cortazar I, Diez N, Garcia-Fernandez M, Puche JE, Diez-Caballero F, Quiroga J, Diaz-Sanchez M, Castilla A, Casares AD, Varela-Nieto I, Prieto J & Gonzalez-Baron S. Hepatocellular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1. World Journal of Gastroenterology 2004 10 2529-2534.
24. Waites GM & Gladwell RT. Physiological significance of fluid secretion in the testis and blood-testis barrier. Physiological Reviews 1982 62 624-671.
25. Cox TM & Kelly AL. Haemochromatosis, an inherited metal and toxicity syndrome. Current Opinion in Genetics and Development 1998 8 274-281.
26. Piperno A, Rivolta MR, D'Alba R, Fargion S, Rovelli F, Ghezzi A, Micheli M & Fiorelli G. Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction. Journal of Endocrinological Investigation 1992 15 423-428.
27. Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS & Bunn HF. Clinical consequences of acquired transfusional iron overload in adults. New England Journal of Medicine 1981 304 319-324.
28. Papadimas J, Mandala E, Pados G, Kokkas B, Georgiadis G, Tarlatzis B, Bontis J, Sinakos Z & Mantalenakis S. Pituitary testicular axis in men with β-thalassaemia major. Human Reproduction 1996 11 1900-1904.
29. Procci WR, Goldstein DA, Adelstein J & Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney International 1981 19 317-323.
30. Toorians AW, Janssen E, Laan E, Gooren LJG, Giltay EJ, Oe PL, Donker AJM & Everaerd W. Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrology Dialysis Transplantation 1997 12 2654-2663.
31. De Celis R & Pendron-Nuevo N. Male fertility of kidney transplant patients with one to ten years of evolution using a conventional immunosuppressive regimen. Archives of Andrology 1999 42 9-20.
32. Prem AR, Punekar SV, Kalpana M, Kelkar AR & Acharya VN. Male reproductive function in uremia: efficacy of haemodialysis and renal transplantation. British Journal of Urology 1996 78 635-638.
33. Handelsman DJ. Hypothalamic-pituitary-gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocrine Reviews 1985 6 151-182.
34. Lim VS & Fang VS. Restoration of plasma testosterone levels in uremic men with clomiphene citrate. Journal of Clinical Endocrinology and Metabolism 1976 43 1370-1377.
35. Stewart-Bentley M, Gans D & Horton R. Regulation of gonadal dysfunction in uremia. Metabolism (Clinical and Experimental) 1974 23 1065-1072.
36. Dunkel L, Raivio T, Laine J & Holmberg C. Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure. Kidney International 1997 51 777-784.
37. Handelsman DJ, Ralec VL, Tiller DJ, Horvath JS & Turtle JR. Testicular function after renal transplantation. Clinical Endocrinology 1981 14 527-538.
38. Ferraris J, Saenger P, Levine L, New M, Pang S, Saxena BB & Lewy JE. Delayed puberty in males with chronic renal failure. Kidney International 1980 18 344-350.
39. Schaefer F, Veldhuis JD, Robertson WR, Dunger D & Schärer K. Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Kidney International 1994 45 1465-1476.
40. Veldhuis JD, Wilkowski MJ, Zwart AD, Urban RJ, Lizarralde G, Iranmanesh A & Bolton WK. Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. Journal of Clinical Endocrinology and Metabolism 1993 76 648-654.
41. Gomez F, de la Cueva R, Wauters J-P & Lemarchand-Beraud T. Endocrine abnormalities in patients undergoing long-term hemodialysis: the role of prolactin. American Journal of Medicine 1980 68 522-530.
42. Isaac R, Merceron RE, Caillens G, Raymond J-P & Ardaillou R. Effect of parathyroid hormone on plasma prolactin in man. Journal of Clinical Endocrinology and Metabolism 1978 47 18-23.
43. Massry SG, Goldstein DA, Procci WR & Kletzky OA. Impotence in patients with uremia: a possible role for parathyroid hormone. Nephron 1977 19 305-310.
44. Caticha O, Norato DYJ, Tambascia MA, Santana A, Stephanou A & Sarlis NJ. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic renal insufficiency. Journal of Endocrinological Investigation 1996 19 441-448.
45. Steele TE, Wuerth D, Finkelstein S, Juergensen D, Juergensen P, Kliger AS & Finkelstein FO. Sexual experience of the chronic peritoneal dialysis patient. Journal of the American Society of Nephrology 1996 7 1165-1168.
46. Schaefer F, van Kaick B, Veldhuis JD, Stein G, Schärer K, Robertson WR & Ritz E. Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. Journal of the American Society of Nephrology 1994 5 1208-1215.
47. Kokot F, Wiecec A, Schmidt-Gayk H, Marcinkowski W, Gilge U, Heiland A, Rudka R & Trembecki J. Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artificial Organs 1995 19 428-435.
48. MacDougal IC, Mahon A, Muir G & Sidhu P. Randomized placebo-controlled study of sildenafil (Viagra) in peritoneal dialysis patients with erectile dysfunction. Journal of the American Society of Nephrology 1999 10 318A.
49. Chen J, Mabjeesh NJ, Greenstein A, Nadu A & Matzkin H. Clinical efficacy of sildenafil in patients on chronic dialysis. Journal of Urology 2001 165 819-821.
50. Turk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A & Yeksan M. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation 2001 16 1818-1822.
51. Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A & Cupta S. A comparison of androgens for anemia in patients on hemodialysis. New England Journal of Medicine 1981 304 871-875.
52. Teruel JL, Marcen R, Navarro-Antolin J, Aguilera A, Fernandez-Juarez G & Ortuno J. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. Journal of the American Society of Nephrology 1996 7 140-144.
53. Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA & McDonald FD. Effect of oral zinc therapy on gonadal function in hemodialysis patients. Annals of Internal Medicine 1982 97 357-361.
54. Glass AR, Swerdloff RS, Bray GA, Dahms WT & Atkinson RL. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. Journal of Clinical Endocrinology and Metabolism 1977 45 1211-1219.
55. Amatruda JM, Hochstein M, Hsu TH & Lochwood DR. Hypothalamic and pituitary dysfunction in obese males. International Journal of Obesity 1982 6 183-189.
56. Vermeulen A, Kaufman JM, Deslypere JP & Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. Journal of Clinical Endocrinology and Metabolism 1993 76 1140-1146.
57. Santen RJ. Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men? Journal of Clinical Investigation 1975 56 1555-1563.
58. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K & Mendelson CR. Aromatase expression in health and disease. Recent Progress in Hormone Research 1997 59 185-213.
59. Killinger DW, Perel E, Danilescu D, Kharlip L & Lindsay WR. Influence of adipose tissue distribution on the biological activity of androgens. Annals of the New York Academy of Sciences 1990 595 199-211.
60. Schneider G, Kirschner MA, Berkowitz R & Ertel NH. Increased estrogen production in obese men. Journal of Clinical Endocrinology and Metabolism 1979 48 633-638.
61. Seidell JC, Bjorntorp P, Sjostrom L, Kvist H & Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990 39 897-901.
62. Ebeling P, Stenman UH, Seppala M & Koivisto VA. Androgens and insulin resistance in type 1 diabetic men. Clinical Endocrinology 1995 43 601-607.
63. Rosner W, Aden DP & Khan MS. Hormonal influences on the secretion of steroid-binding proteins by a human hepatoma-derived cell line. Journal of Clinical Endocrinology and Metabolism 1984 59 806-808.
64. Oyadomari S, Matsuno F, Chowdhury S, Kimura T, Iwase K, Araki E, Shichiri M, Mori M & Takiguchi M. The gene for hepatocyte nuclear factor (HNF)-4 alpha is activated by glucocorticoids and glucagons, and repressed by insulin in rat liver. FEBS Letters 2000 478 141-146.
65. Barrett-Connor E, Khaw KT & Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. American Journal of Epidemiology 1990 132 895-901.
66. Stellato RK, Feldman HA, Hamdy O, Horton ES & McKinlay JB. Testosterone, sex hormone-binding globulin and the development of type-2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000 23 490-494.
67. Hack AE, Witteman JC, de Jong FH, Geertings MI, Hofman A & Pots HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. Journal of Clinical Endocrinology and Metabolism 2002 87 3632-3639.
68. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T & Uchida K. Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion rnolecule-1 expression in human aortic endothelial cells. FEBS Letters 2002 530 129-132.
69. Langer C, Gansz B, Goepfert C, Engel T, Uehara Y, von Dehn G, Jansen H, Assmann G & von Eckardstein A. Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochemical and Biophysical Research Communications 2002 296 1051-1057.
70. Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G & Kaufman JM. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis 2003 166 95-102.
71. Freedman DS, O'Brien TR, Flanbers WD, DeStefano F & Barboriak JJ. Relation of serum testosterone levels to high density lipoprotein cholesterol and other characteristics in men. Arteriosclerosis Thrombosis and Vascular Biology 1991 11 307-315.
72. De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E & Giorgino R. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 1997 46 1287-1293.
73. Bergendahl M, Aloi JA, Iranmanesh A, Mulligan TM & Veldhuis JD. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not in older men. Journal of Clinical Endocrinology and Metabolism 1998 83 1967-1975.
74. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E & Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 250-252.
75. Finn PD, Cunningham MJ, Pau KY, Spies HG, Clifton DK & Steiner RA. The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. Endocrinology 1998 139 4652-4662.
76. Wheeler MJ, Crisp AH, Hsu LK & Chen CN. Reproductive hormone changes during weight gain in male anorectics. Clinical Endocrinology 1983 18 423-429.
77. Gordon D, Beastall GH, Thomson JA & Sturrock RD. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Quarterly Journal of Medicine 1986 60 671-679.
78. Vilaricho ST & Costallat LT. Evaluation of the hypothamic-pituitary-gonadal axis in males with systemic lupus erythematosus. Journal of Rheumatology 1988 25 1097-1103.
79. Gordon D, Beastall GH, Thomson JA & Sturrock RD. Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity. British Journal of Rheumatology 1988 27 440-444.
80. Tengstrand B, Calstrom K & Hafstrom I. Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism. Rheumatology 2002 41 285-289.
81. Mitra D, Elvis DM & Collins AJ. Testosterone and testosterone free index in mild ankylosing spondylitis: relationship with bone mineral density and vertebral fractures. Journal of Rheumatology 1999 26 2414-2417.
82. O'Morain C, Smethurst P, Dore CJ & Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984 25 1078-1084.
83. Silva CA, Hallak J, Pasqualotto FF, Barba MF, Saito MI & Kiss MH. Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus. Journal of Rheumatology 2002 29 2000-2005.
84. Baker HW. Reproductive effects of nontesticular illness. Endocrinology and Metabolism Clinics of North America 1998 27 831-850.
85. Lo JC & Schambelan M. Reproductive function in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism 2001 86 2338-2343.
86. Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD & Beall G. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. Journal of the American Medical Association 2000 283 763-770.
87. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D. Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N & Klibanski A. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Annals of Internal Medicine 2000 133 348-355.
88. Farthing MJ, Rees LH & Dawson AM. Male gonadal function in coeliac disease: III. Pituitary regulation. Clinical Endocrinology 1983 19 661-671.
89. Farthing MJ, Rees LH, Edwards CR & Dawson AM. Male gonadal function in coeliac disease: 2. Sex hormones. Gut 1983 24 127-135.
90. Norgard B, Fonager K, Sorensen HT & Olsen J. Birth outcomes of women with celiac disease: a nationwide historical cohort study. American Journal of Gastroenterology 1999 94 2435-2440.
91. Ludvigsson JF & Ludvigsson J. Coeliac disease in the father affects the newborn. Gut 2001 49 169-175.
92. Marshall JC. Control of pituitary hormone secretion - role of pulsatility. In Comprehensive Clinical Endocrinology, edn 3, ch. 2, pp 19-34. Eds CM Besser & MO Thoner. Edinburgh: Mosby, 2002.
93. Reame NE, Sauder SE, Case GD, Kelch RP & Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. Journal of Clinical Endocrinology and Metabolism 1985 61 851-858.
94. Hobart JA & Smucker DR. The female athlete triad. American Family Physician 2000 61 3357-3364.
95. Rebar RW. Disorders of menstruation, ovulation and sexual response. In Principles and Practice of Endocrinology and Metabolism edn 3, ch. 96, pp 947-967. Ed. KL Becker. Philadelphia: Lippincott Williams & Wilkins, 2000.
96. Young EA & Korszun A. The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinology and Metabolism Clinics of North America 2002 31 63-78.
97. Mantzoros C, Flier JS, Lesem MD, Brewerton TD & Jimerson DC. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. Journal of Clinical Endocrinology and Metabolism 1997 82 1845-1851.
98. Kopp W, Blum WF, von Prittwitz S, Ziegler A, Lubbert H, Emons G, Herzog W, Herpertz S, Deter HC, Remschmidt H & Hebebrand J. Low leptin levels predict amenorrhea in under-weight and eating disordered females. Molecular Psychiatry 1997 2 335-340.
99. Audi L, Mantzoros CS, Vidal-Puig A, Vargas D, Gussinye M & Carrascosa A. Leptin in relation to resumption of menses in women with anorexia nervosa. Molecular Psychiatry 1998 3 544-547.
100. Caprio M, Fabbrini E, Isidori AM, Aversa A & Fabbri A. Leptin in reproduction. Trends in Endocrinology and Metabolism 2001 12 65-72.
101. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A & Mantzoros CS. Recombinant human leptin in women with hypothalamic amenorrhea. New England Journal of Medicine 2004 351 987-997.
102. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinology and Metabolism Clinics of North America 2004 33 283-303.
103. Sam S & Dunaif A. Polycystic ovary syndrome. Syndrome XX? Trends in Endocrinology and Metabolism 2003 14 365-370.
104. Urbanek M, Legro RS, Driscoll D, Strauss JF 3rd, Dunaif A & Spielman RS. Searching for the polycystic ovary syndrome genes. Journal of Pediatric Endocrinology and Metabolism 2000 13 (Suppl 5) 1311-1313.
105. Ginsburg ES & Owen WF Jr. Reproductive endocrinology and pregnancy in women on hemodialysis. Seminars in Dialysis 1993 6 105-116.
106. Holley JL, Schmidt PJ, Bender FH, Dumler F & Schiff M. Gynecologic and reproductive issues in women on dialysis. American Journal of Kidney Diseases 1997 29 685-690.
107. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. American Journal of Kidney Diseases 1999 33 235-252.
108. Valimaki MJ, Laitinen K, Tiitinen A, Steman UH & Ylostalo P. Gonadal function and morphology in non-cirrhotic female alcoholics: a controlled study with hormone measurements and ultrasonography. Acta Obstetricia et Gynecologica Scandinavica 1995 74 462-466.
109. Saxena S, Meehan D, Coney P & Wimalasena I. Ethanol has direct inhibitory effects on steroidogenesis in human granulosa cells: specific inhibition of LH action. Alcoholism-Clinical and Experimental Research 1990 14 522-527.
110. Gavaler JS. Alcohol effects on hormone levels in normal postmenopausal women and in postmenopausal women with alcohol-induced cirrhosis. Recent Developments in Alcoholism 1995 12 199-208.
111. Ouellette EM, Rosett HL, Rosman NP & Weiner L. Adverse effects on offspring of maternal alcohol abuse during pregnancy. New England Journal of Medicine 1977 297 528-530.
112. Østensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Practice and Research Clinical Rheumatology 2004 18 219-232.
113. Masi AT. Hormonal and pregnancy relationship to rheumatoid arthritis: convergent effects with immunological and microvascular systems. Seminars in Arthritis and Rheumatism 1995 25 1-27.
114. Cutolo M, Balleari E, Giusti M, Monachesi M & Accardo S. Sex hormones status in women suffering from rheumatoid arthritis. Journal of Rheumatology 1986 13 1019-1023.
115. Skomsvoll JF, Østensen M, Baste V & Irgens LM. Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. Journal of Rheumatology 2001 28 2310-2314.
116. Kay A & Bach F. Subfertility before and after the development of rheumatoid arthritis in women. Annals of the Rheumatic Diseases 1965 24169-173.
117. Nelson JL, Koepsell TD, Dugowson CE, Voigt LF, Daling JR & Hansen JA. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis and Rheumatism 1993 36 7-14.
118. Petri M & Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. Journal of Rheumatology 1993 20 650-656.
119. Julkunen H, Jouhikainen T, Kaaja R, Leirisalo-Repo M, Stephansson E, Palosuo T, Teramo K & Friman C. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 1993 2 125-131.
120. Hayslett P. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. American Journal of Reproductive Immunology 1992 28 199-204.
121. Packham DK, Lam SS, Nicholls K, Fairley KF & Kincaid-Smith PS. Lupus nephritis and pregnancy. Quarterly Journal of Medicine 1992 83 315-324.
122. Lima F, Buchanan NM, Khamashta MA, Kerslake S & Hughes GR. Obstetric outcome in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 1995 25 184-192.
123. Ghazeeri GS & Kutteh WH. Autoimmune factors in reproductive failure. Current Opinion in Obstetrics and Gynecology 2001 13 287-291.
124. Fichorova R, Nakov L, Baleva M, Nikolov K & Gegova I. Sperm, nuclear, phospholipid, and red blood cell antibodies and isotype RF in infertile couples and patients with autoimmune rheumatic diseases. American Journal of Reproductive Immunology 1996 36 309-316.
125. Sher KS, Jayanthi V, Probert CS, Stewart CR & Mayberry JF. Infertility, obstetric and gynaecological problems in coeliac sprue. Digestive Diseases 1994 12 186-190.